Institutional investors hold a majority ownership of BMY through the 71.47% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2017, these large investors purchased a net $19.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 7.9 Million shares of Bristol-Myers Squibb
DODGE & COX Bought 6.6 Million shares of Bristol-Myers Squibb
RENAISSANCE TECHNOLOGIES LLC Bought 5.9 Million shares of Bristol-Myers Squibb